Delivery Order SPE2DR25D3012-SPE2DR26F4C9Y
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,114.47 by the Defense Logistics Agency on September 23, 2025, for the supply of Zilretta 32 mg vials with an ultimate completion date of October 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performable at the company's corporate office location in Conshohocken, Pennsylvania. Zilretta is an...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,287.25 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, for the supply of Zilretta 32 mg vials. The competitively awarded, firm fixed-price contract carries an ultimate completion date of September 8, 2025, and involves performance at the vendor's Conshohocken facility. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency valued at $3,714.90 for the supply of Zilretta 32 mg vials. This is a firm fixed-price, non-set-aside contract with a completion deadline of May 23, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen's broader federal pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $8,631.84 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on November 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing at its corporate office location in the same city and serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with a firm fixed price and no set-aside designation. The order, placed under a competitive award process, is scheduled for completion by September 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,114.47 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, a specialized pharmaceutical product. This competitively awarded, firm fixed-price contract is scheduled for completion by September 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,438.60 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of December 31, 2025. This non-competitive delivery order represents a firm fixed-price transaction issued under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $8,915.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of August 13, 2025. This non-set-aside contract, executed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zilretta 32 mg vials, with a ceiling value of $1,438.64 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation and reflects competitive...
- The Defense Logistics Agency awarded a $7,429.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 7, 2025. This non-set-aside competitive award was issued on September 16, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C9YDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,473.88 by the Defense Logistics Agency on December 8, 2025, for the supply of Zilretta 32 mg vials. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of December 30, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The Defense Logistics Agency utilizes such delivery orders to procure critical medical commodities for the Department of Defense healthcare system, including specialty medications and pharmaceutical products distributed across military installations and veteran healthcare facilities worldwide. This particular delivery order for Zilretta, an intra-articular corticosteroid injection used for osteoarthritis pain management, demonstrates AmerisourceBergen's role as a key supplier within the federal medical supply chain. The transaction reflects the agency's ongoing need for diverse pharmaceutical products to support military medical operations and healthcare readiness across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 12/7/25 |